VYNE - VYNE Therapeutics Inc.

📈 Is growth accelerating? 7 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q4 FY2014 Dec 31, 2014 10-K ↗
Revenue Growth YoY (%)	40.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+407%)	-57.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-818%)	—	-65.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-914%)	106.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1227%)	10.5% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+32%)	6.1% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-23%)	46.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+483%)	-1.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-113%)	1166.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+14483%)	-31.7% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-497%)	7.1% Fair ↑ Fair Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-11%)	-44.4% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-655%)	-97.8% Weak → Weak Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1323%)	-95.9% Weak → Weak Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1299%)	-97.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1313%)	-95.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1296%)	-93.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1270%)	25.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+212%)	-63.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-895%)	135.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1592%)	3074.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+38335%)	—	—	—	—	—	N/M	—	—	N/M	2159.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+26888%)	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	-2600.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	60.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	—	40.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-33.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	85.6% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	92.9% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	91.4% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	N/M	96.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	93.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	87.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	61.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	61.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	N/M	30.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	91.9% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	47.7% Excellent → Excellent Stable Year-over-year change in net income	58.4% Excellent ↑ Excellent Improving Year-over-year change in net income	—	38.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-37.8% Weak ↑ Weak Improving Year-over-year change in net income	-94.3% Weak ↓ Weak Declining Year-over-year change in net income	-84.6% Weak ↓ Weak Declining Year-over-year change in net income	6.5% Fair ↓ Fair Declining Year-over-year change in net income	-11.2% Weak ↓ Weak Declining Year-over-year change in net income	37.8% Excellent ↑ Excellent Improving Year-over-year change in net income	30.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-18.7% Weak ↓ Weak Declining Year-over-year change in net income	N/M	14.0% Fair ↓ Fair Declining Year-over-year change in net income	55.6% Excellent → Excellent Stable Year-over-year change in net income	57.5% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	50.1% Excellent → Excellent Stable Year-over-year change in net income	13.9% Fair ↓ Fair Declining Year-over-year change in net income	88.1% Excellent ↑ Excellent Improving Year-over-year change in net income	48.9% Excellent ↑ Excellent Improving Year-over-year change in net income	38.7% Excellent ↑ Excellent Improving Year-over-year change in net income	-6.7% Weak ↑ Weak Improving Year-over-year change in net income	-781.6% Weak ↓ Weak Declining Year-over-year change in net income	-113.2% Weak ↓ Weak Declining Year-over-year change in net income	—	-80.3% Weak ↑ Weak Improving Year-over-year change in net income	-127.5% Weak ↓ Weak Declining Year-over-year change in net income	-49.1% Weak ↓ Weak Declining Year-over-year change in net income	—	-57.2% Weak ↑ Weak Improving Year-over-year change in net income	-35.7% Weak Weak Year-over-year change in net income	-131.2% Weak Weak Year-over-year change in net income	—	—	—	—	—	—	—
FCF Growth YoY (%)	—	64.5% Excellent Excellent Year-over-year change in free cash flow	—	—	-43.3% Weak Weak Year-over-year change in free cash flow	—	—	—	88.9% Excellent Excellent Year-over-year change in free cash flow	—	—	—	97.1% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	-10.4% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-4.6% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	—	-18.2% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	4.3% Caution ↑ Caution Improving Compound annual revenue growth over 3 years	-32.5% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-69.1% Weak → Weak Stable Compound annual revenue growth over 3 years	-64.0% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-71.2% Weak → Weak Stable Compound annual revenue growth over 3 years	-73.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-67.3% Weak → Weak Stable Compound annual revenue growth over 3 years	-77.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-61.6% Weak Weak Compound annual revenue growth over 3 years	-64.6% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	-25.1% Weak Weak Compound annual revenue growth over 3 years	—	—	53.2% Excellent Excellent Compound annual revenue growth over 3 years	196.4% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	-53.1% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	-53.9% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	—	-64.2% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-35.1% Weak Weak Compound annual revenue growth over 5 years	-9.1% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	-57.8% Weak Weak Compound annual revenue growth over 5 years	—	—	-28.7% Weak Weak Compound annual revenue growth over 5 years	-22.4% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS CAGR 3Y (%)	—	—	—	—	—	—	—	—	—	-90.8% Weak Weak Compound annual EPS growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q4 FY2014 Dec 31, 2014 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-435.0% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3000%)	-441.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3041%)	-471.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3245%)	—	—	—	—	—	—	—	—	—	—	-90.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-703%)	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	5.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.2% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-467.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3999%)	-498.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4258%)	—	—	—	—	—	—	—	—	—	—	-82.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-786%)	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-304.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	-307.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	8.2% Caution Caution Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—
FCF / Net Income (x)	0.66x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.14x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	1.33x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.70x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	—	1.28x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.97x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.48x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	-2.14x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.61x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.21x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.30x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.59x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	0.89x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	—	1.53x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-0.01x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.02x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q4 FY2014 Dec 31, 2014 10-K ↗
Return on Invested Capital (%)	-14.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-15.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	—	-19.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-20.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-54.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-59.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-22.2% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-25.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-23.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-15.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-17.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-30.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-25.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-15.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-31.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-47.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-233.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-30.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-74.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-43.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-32.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	—	-7.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-6.3% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—
Return on Capital (%) (%)	-13.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-16.9% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-16.3% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-19.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-17.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-32.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-41.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-21.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-23.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-24.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-46.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-15.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-8.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-7.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	-13.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-191%)	-14.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-197%)	—	-14.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-199%)	-19.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-230%)	-23.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-254%)	-19.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-228%)	-12.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-184%)	-7.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-150%)	-7.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-146%)	-57.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-482%)	-58.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-488%)	-21.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-242%)	-31.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-312%)	-23.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-257%)	-17.5% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-217%)	8.4% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-44%)	-23.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-259%)	-36.1% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-341%)	-26.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-277%)	-22.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-247%)	-61.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-512%)	-49.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-433%)	-234.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1661%)	-57.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-486%)	-215.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1535%)	-43.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-388%)	-31.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-310%)	-16.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-209%)	—	-8.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-158%)	-5.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-135%)	-7.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-151%)	—	—	—	—	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q4 FY2014 Dec 31, 2014 10-K ↗
Debt to Equity (x)	0.00x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	0.00x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	0.00x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	0.00x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.38x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-37%)	0.88x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+47%)	—	—	0.47x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-21%)	1.86x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+210%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-5.12x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-17.49x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-18.30x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-18.94x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-21.51x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-156.24x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-41.00x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-72.96x Weak Weak Operating income divided by interest expense Optimal: > 5x	-80.27x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-22.93M	$-24.63M	$-24.03M	$-22.05M	$-28.21M	$-19.93M	$-16.27M	$-29.61M	$-19.07M	$-30.62M	$-15.45M	$-20.63M	$-30.21M	$-30.91M	$-35.51M	$-42.81M	$-50.49M	$-42.25M	$-52.31M	$-103.41M	$-83.52M	$-24.39M	$-72.96M	$-96.51M	$-24.78M	$-11.03M	$-40.53M	$-39.09M	$-61.96M	$-49.51M	$-70.20M	$-73.58M	$-78.53M	$-10.21M	$-14.96M	$-13.42M	$-6.03M	$-4.03M	$-43.81M	$-273.00K
Debt / EBITDA (x)	0.00x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	0.00x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	0.00x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	0.00x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	0.00x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.80x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.51x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	-0.82x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.88x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q4 FY2014 Dec 31, 2014 10-K ↗
Revenue per Share (USD)	$0.11	$0.00	—	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.03	$0.04	$0.03	—	$0.93	$0.70	$1.04	—	$25.45	$26.84	—	—	$25.26	$109.27	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-3.51	$-0.08	—	$-0.13	$-0.20	$-0.28	$-0.29	$-0.22	$-0.15	$4.04	$-2.01	$-3.09	$-1.74	$-3.10	$-51.85	$-48.61	$25.93	$-24.42	$-132.87	$-126.39	—	$5.14K	$-191.20	$-1.57K	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-2.32	$-0.10	—	—	$-0.27	—	$-0.20	—	$-0.19	—	—	—	$-1.68	—	—	—	$-58.36	—	—	—	—	—	$-182.67	$-335.91	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$33.01	$0.74	$0.83	$1.97	$2.77	$3.51	$4.31	$5.15	$5.83	$6.29	$3.48	$5.26	$8.08	$9.66	$223.74	$270.16	$311.88	$16.34	$356.62	$471.16	$585.87	$281.22	$382.66	$668.72	$1.47K	$624.50	—	—	$6.33K	$7.27K	$8.20K	$8.92K	$9.35K	—	—	—	—	$-7.23K	—	—
Tangible Book Value per Share (USD)	$33.01	$0.74	$0.83	$1.97	$2.77	$3.51	$4.31	$5.15	$5.83	$6.29	$3.48	$5.26	$8.08	$9.66	$223.74	$270.16	$311.88	$16.34	$356.62	$471.16	$585.87	$281.22	$382.66	$668.72	$1.38K	$624.50	—	—	$6.33K	$7.27K	$8.20K	$8.92K	$9.35K	—	—	—	—	$-7.23K	—	—
Basic Weighted Avg Shares (shares)	858,000	42.77M	—	42.76M	42.67M	—	42.59M	42.59M	42.58M	—	3.28M	3.27M	3.25M	—	178,760	178,760	170,910	—	160,548	158,644	—	—	129,400	106,963	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q4 FY2014 Dec 31, 2014 10-K ↗
Working Capital (USD)	$21.98M	$24.55M	$27.61M	$38.51M	$42.62M	$49.62M	$60.87M	$72.02M	$83.29M	$88.42M	$11.06M	$16.59M	$25.50M	$28.93M	—	—	—	—	$55.13M	$70.81M	$121.57M	$65.49M	—	—	$41.85M	$47.09M	—	—	$114.59M	$129.96M	$146.41M	$147.51M	$151.19M	$56.04M	—	—	—	$27.64M	—	—
LT Debt (USD)	$0.00	$0.00	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$35.00M	$33.17M	—	—	$32.82M	$32.73M	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$22.06M	$24.64M	$27.77M	$38.88M	$44.13M	$52.09M	$63.54M	$74.87M	$83.37M	$88.73M	$11.51M	$17.27M	$26.43M	$31.20M	$40.07M	$48.36M	$55.73M	$48.64M	$58.89M	$74.89M	$92.90M	$37.49M	$49.52M	$71.53M	$69.53M	$17.57M	$53.53M	$60.38M	$115.63M	$130.38M	$146.88M	$158.19M	$165.70M	$-57.03M	—	—	—	$-29.44M	$-15.95M	$-11.41M

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q4 FY2014 Dec 31, 2014 10-K ↗
Sales/Revenue/Turnover (USD)	$97.00K	$86.00K	—	$69.00K	$202.00K	$84.00K	$121.00K	$198.00K	$98.00K	$76.00K	$114.00K	$135.00K	$99.00K	$6.00K	$167.00K	$126.00K	$178.00K	$273.00K	$4.09M	$4.26M	$4.12M	$4.29M	$3.27M	$11.69M	$1.75M	$135.00K	$0.00	$0.00	$0.00	$0.00	$0.00	$10.14M	—	—	$909.00K	$449.00K	—	—	—	—
Depreciation Expense (USD)	$6.00K	$6.00K	—	$6.00K	$6.00K	—	—	—	—	$0.00	$0.00	$0.00	$0.00	$-155.00K	—	—	$44.00K	$26.00K	—	—	$27.00K	$87.00K	$67.00K	$94.00K	$93.00K	$94.00K	$93.00K	$87.00K	—	—	—	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-3.01M	$-3.58M	—	$-5.75M	$-8.61M	$-12.02M	$-12.16M	$-9.41M	$-6.25M	$-6.19M	$-6.58M	$-10.06M	$-5.62M	$-9.95M	$-9.46M	$-8.48M	$4.67M	$-11.57M	$-21.29M	$-19.92M	$-20.55M	$-23.18M	$-24.71M	$-167.44M	$-40.23M	$-37.82M	$-23.16M	$-18.99M	$-18.87M	—	$-12.85M	$-8.35M	$-12.66M	—	$-8.17M	$-6.15M	$-5.47M	—	—	—
Operating Cash Flow (USD)	$-1.99M	$-4.08M	—	—	$-11.46M	$-9.00M	$-8.51M	—	$-7.98M	$-5.14M	—	—	$-5.48M	$-4.81M	—	—	$-9.97M	$-10.02M	—	—	$-12.55M	$-25.38M	$-23.64M	$-35.86M	$-52.21M	$-22.25M	$-21.79M	$-12.72M	$-18.06M	—	—	—	$-11.29M	—	$-12.52M	$37.00K	$-5.58M	—	—	—

VYNE Therapeutics Inc.

Analytical Summary

40-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare VYNE with peers